State Of The Union
Good Morning Europe
The Global Conversation
Top News Stories Today
Women Beyond Borders
Farm To Fork
Green In The City
Low Impact Living
Cry Like A Boy
Meet The Locals
Depth Of Field
Here We Grow: Spain
The New Uzbekistan
Digital Garden City Nation
More about this topic
EU ends legal dispute with AstraZeneca over vaccine delays
More about this topic
EU's legal action against AstraZeneca: Why now? How will it play out?
After months of accusations and criticism, Brussels has today revealed it's taking AstraZeneca to court.
EU begins legal action against AstraZeneca over 'breach of contract'
"The company has not been in the position to come up with a reliable strategy to ensure the timely delivery of doses," said a European Commission spokesperson.
COVID mass vaccination centre in Nice closes as just 58 people turn up
More than 4,000 doses of the AstraZeneca jab were available at the centre this weekend but it closed after a few hours due to low turnout.
Mix and match COVID vaccine study expanded to include Moderna, Novavax
The aim of the study is to assess how well people's immune systems respond when their second "boost" dose is a different type of vaccine to their first "prime" dose.
EU received only half of AstraZeneca doses it was meant to this week
AstraZeneca's deliveries to the European Union have been beset by delays.
state of the union
Europe's week: AstraZeneca jab troubles and Turkey's diplomacy mistake
The European Medicines Agency said the Oxford/AstraZeneca vaccine could potentially cause rare blood clots and Commission President von der Leyen got sidelined in Ankara. Here's a look at two key stories making the news in Brussels this week.
AstraZeneca: France says under 55s to receive different second dose
France's health authority has recommended that adults under 55 who received a first dose of AstraZeneca's COVID-19 vaccine should receive a different vaccine for their second dose.
Countries change tack on AstraZeneca vaccine despite EU call for unity
Countries are changing their recommendations for who should receive the AstraZeneca coronavirus jab after the EMA confirmed a "possible link" between the vaccine and a rare form of blood clot.
Possible link between AstraZeneca jab and rare blood clots, says EMA
The EU medicines regulator said there was a "possible link" between the AstraZeneca jab and "very rare" blood clots. They maintained that the benefits of the vaccine outweigh the risks.
Vaccine hesitancy 'rises in France' after AstraZeneca suspension
Vaccine hesitancy has risen sharply in France since countries across Europe suspended the AstraZeneca jab amid reports it causes blood clots.
Brussels tightens vaccine export rules to ensure jabs stay in the bloc
The EU plans to incorporate the principles of "proportionality and reciprocity" into the transparency mechanism that was introduced at the end of January and will assess "case by case" the export requests from pharmaceutical companies.
state of the union
Europe's week: AstraZeneca vaccine doubts and Rutte's decisive victory
Mark Rutte set for a historic fourth term as Dutch PM, as Europe's vaccination campaign continues to stutter.
Many EU countries to restart AstraZeneca vaccinations post EMA verdict
"Its benefits in protecting people from COVID-19 with the associated risks of death and hospitalisation outweigh the possible risks," EMA executive director Emer Cooke said at a press conference. Yet the EMA will continue to investigate reports of blood clots.
UK to have a 'a significant reduction' in vaccine supply from March 29
The NHS said there would be "a significant reduction" in COVID-19 vaccine supplies from 29 March. UK health minister Matt Hancock says they are on track to meet their target to vaccinate everyone over 50 by April 15.
AstraZeneca jab pause 'will definitely increase vaccine hesitancy'
"We have already seen a problem before now with vaccine hesitancy, but it [the halt] will definitely increase that," Dr William Budd told Euronews.
Watch: EMA 'convinced' benefits of AstraZeneca jab outweigh risks
Over a dozen European countries have temporarily suspended the use of the AstraZeneca vaccine following reports of serious blood clotting events.
WHO reaffirms safety of Oxford-AstraZeneca COVID-19 vaccine
The World Health Organization tells Euronews the Oxford-AstraZeneca COVID-19 vaccine is safe
Is there any substance behind the AstraZeneca vaccine doubts?
Despite being shown to prevent against severe disease, AstraZeneca's COVID vaccine has attracted negative publicity. Here's a closer look.
COVID vaccine: EU says it has exported 34m doses to over 30 countries
The latest vaccine exports figures from the EU Commission come days after London and Brussels lobbed accusations of vaccine nationalism at each other.
'No indication' AstraZeneca COVID jab led to Austria death, says EMA
Austria suspended the use of an AstraZeneca vaccine batch on Sunday following the death of a woman and the hospitalisation of another.
EU to receive 100m doses per month from April, says Von der Leyen
European Commission President Ursula von der Leyen told German newspapers that the bloc will receive 300 million doses of the COVID-19 vaccines between April and June.
EU first as Italy blocks export of 250,000 COVID vaccines to Australia
The shipment is estimated to be around 250,000 doses.
France widens AstraZeneca jab use, backs one dose for COVID patients
Health Minister Olivier Véran told France 2 on Monday evening that the AstraZeneca jab has now been approved for people aged 65-74 with "co-morbidities".
MEPs grill AstraZeneca's CEO Soriot over COVID vaccine delivery delays
"How is it possible that you have no clue?" said Finnish MEP Silvia Modig, who called Soriot a "piece of soap" over his alleged conflicting statements in recent weeks.
Oxford/AstraZeneca to begin COVID vaccine trials on children
Pfizer and Moderna began trialling their vaccines on children as young as 12 last year, while AstraZeneca will be expanding the age group further.
EU visit to vaccine plant under scrutiny over AstraZeneca delays
The site at Seneffe, south of Brussels, manufactures the active ingredient of AstraZeneca's COVID-19 vaccine.